Essex Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-119,112
Closed -$2.23M 418
2023
Q1
$2.23M Sell
119,112
-35,173
-23% -$578K 0.32% 101
2022
Q4
$2.13M Sell
154,285
-881
-0.6% -$13.5K 0.33% 98
2022
Q3
$2.97M Buy
155,166
+4,159
+3% +$75.8K 0.47% 65
2022
Q2
$2.3M Sell
151,007
-62,303
-29% -$921K 0.37% 79
2022
Q1
$4.34M Buy
213,310
+6,822
+3% +$139K 0.54% 50
2021
Q4
$6.03M Buy
206,488
+13,356
+7% +$382K 0.69% 38
2021
Q3
$4.17M Sell
193,132
-45,104
-19% -$1.09M 0.51% 52
2021
Q2
$6.11M Buy
238,236
+13,378
+6% +$286K 0.71% 31
2021
Q1
$4.1M Sell
224,858
-23,904
-10% -$397K 0.5% 50
2020
Q4
$2.87M Sell
248,762
-45,660
-16% -$417K 0.36% 88
2020
Q3
$2.24M Buy
294,422
+9,837
+3% +$74.5K 0.32% 93
2020
Q2
$1.87M Sell
284,585
-142,763
-33% -$797K 0.31% 90
2020
Q1
$2.18M Sell
427,348
-22,692
-5% -$137K 0.44% 59
2019
Q4
$3.45M Buy
450,040
+21,190
+5% +$124K 0.42% 60
2019
Q3
$2.27M Sell
428,850
-48,692
-10% -$302K 0.33% 89
2019
Q2
$2.67M Buy
477,542
+288,513
+153% +$1.19M 0.37% 76
2019
Q1
$803K Buy
+189,029
New +$771K 0.12% 223

Other funds holding CDMO

Essex Investment Management's CDMO Position: Q2 2023 in Review

Essex Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 119,112 shares — an estimated $2.23M sold.

Essex Investment Management first reported a position in CDMO in Q1 2019 and held it in 17 quarters. The position peaked at $6.11M in Q2 2021. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

  • Essex Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Essex Investment Management sold 119,112 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $2.23M.
  • Essex Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2019 and held it in 17 quarters.
  • Essex Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $6.11M in Q2 2021.
  • 169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.